News Kaleido Biosciences, Inc.

Equities

KLDO

US4833471000

Delayed OTC Markets Other stock markets 02:09:36 2024-04-24 pm EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	+9,900.00%

2022	Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index	CI
2022	Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index	22-04-20	CI
Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index	22-04-20	CI
Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from NASDAQ Composite Index	22-04-15	CI
Top Premarket Gainers	22-04-14	MT
CapitalGainsReport: Must See Healthcare Stocks Under $1 (WHSI, KLDO, AGRX, PTE, AKBA)	22-04-14	AQ
Top Premarket Gainers	22-04-13	MT
Top Midday Decliners	22-04-08	MT
Kaleido Biosciences Ceases Operations, Will Delist From Nasdaq; Shares Fall	22-04-08	MT
KALEIDO BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	22-04-08	AQ
Kaleido Biosciences, Inc. Announces Cessation of All of the Company’s Ongoing Operations	22-04-08	CI
Kaleido Biosciences, Inc. Announces Management Changes	22-04-08	CI
Chardan Cuts Kaleido Biosciences to Neutral From Buy, PT to $1.70 From $3 After Securities Filing Discloses Strategic Review, Potential Liquidation, 'Extremely Limited' Active Development Initiatives in Pipeline	22-04-04	MT
Kaleido Biosciences Initiated Process to Explore Strategic Alternatives	22-04-04	CI
KALEIDO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-04-01	AQ
Kaleido Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-01	CI
Kaleido Biosciences, Inc. Auditor Raises 'Going Concern' Doubt	22-03-31	CI
KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-03-17	AQ
Kaleido Biosciences, Inc. Announces Board Resignations	22-03-17	CI
Radius Health Names New CFO	22-03-16	MT
North American Morning Briefing : Stock Futures -3-	22-03-16	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kaleido Biosciences, Inc.

Equities

KLDO

US4833471000

Summary

Filters